You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬方發展(000638.SZ):與百奧肽克、寧波麗辛共設萬方百奧肽克生物科技
格隆匯 09-11 20:21

格隆匯 9 月 11日丨萬方發展(000638.SZ)公佈,公司2020911日與吉林百奧肽克生物科技合夥企業(有限合夥)(“百奧肽克”)、波麗辛投資合夥企業(有限合夥)(“寧波麗辛”)簽訂了《合資設立公司協議書》,三方將共同出資人民幣5000萬元設立吉林萬方百奧肽克生物科技有限公司(“萬方百奧肽克”)(暫定名,最終名稱以工商核准為準),其中公司認繳出資額為2750萬元,佔註冊資本的55%百奧肽克認繳出資額為1500萬元,佔註冊資本的30%;寧波麗辛認繳出資額為750萬元,佔註冊資本的15%

新設公司擬定經營範圍:生物技術開發、技術推廣、技術服務;生物制品研發、生產、銷售,以自有資金對相關項目投資(不得從事理財、非法集資、非法吸儲、貸款等業務)(依法須經批准的項目,經相關部門批准後方可開展經營活動)。

以上事項,在工商登記時如有變更,以工商登記為準。

公司目前從事互聯網醫療業務,新冠肺炎疫情突發以來,對全球經濟活動以及人類健康造成巨大影響,隨着行業變革,公司也在尋找新的業務方向。疫苗作為人類預防疾病最有效的武器愈發受到關注,相關產品的研發和戰略儲備,都為疫苗行業提供了新的市場空間。

此次公司對外投資將抓住新的機遇,佈局生物科技領域,近期開展傳統疫苗升級和創新疫苗研發,未來逐步向生物製品生產、銷售等業務延伸。公司與戚鳳春博士為首的研發專業團隊合作,逐步充實科研人員力量,提升自身研發技術水平,不斷豐富研發品種。此次對外設立控股子公司,有助於公司持續經營能力增強,吸引高水平人才,滿足未來戰略佈局與發展需要。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account